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Abstract
Background:
19F magnetic resonance imaging (MRI) was recently introduced as a promising technique for in vivo cell
tracking. In the present study we compared
19F MRI with iron-enhanced MRI in mice with photothrombosis (PT) at 7 Tesla.
PT represents a model of focal cerebral ischemia exhibiting acute vessel occlusion and delayed neuroinflammation.
Methods/Principal Findings: Perfluorocarbons (PFC) or superparamagnetic iron oxide particles (SPIO) were injected
intravenously at different time points after photothrombotic infarction. While administration of PFC directly after PT
induction led to a strong
19F signal throughout the entire lesion, two hours delayed application resulted in a rim-like
19F
signal at the outer edge of the lesion. These findings closely resembled the distribution of signal loss on T2-weighted MRI
seen after SPIO injection reflecting intravascular accumulation of iron particles trapped in vessel thrombi as confirmed
histologically. By sequential administration of two chemically shifted PFC compounds 0 and 2 hours after illumination the
different spatial distribution of the
19F markers (infarct core/rim) could be visualized in the same animal. When PFC were
applied at day 6 the fluorine marker was only detected after long acquisition times ex vivo. SPIO-enhanced MRI showed
slight signal loss in vivo which was much more prominent ex vivo indicative for neuroinflammation at this late lesion stage.
Conclusion: Our study shows that vessel occlusion can be followed in vivo by
19F and SPIO-enhanced high-field MRI while in
vivo imaging of neuroinflammation remains challenging. The timing of contrast agent application was the major
determinant of the underlying processes depicted by both imaging techniques. Importantly, sequential application of
different PFC compounds allowed depiction of ongoing vessel occlusion from the core to the margin of the ischemic lesions
in a single MRI measurement.
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Introduction
Among the non invasive imaging modalities MRI provides high
resolution imaging with excellent soft tissue contrast allowing in
vivo follow up of pathological processes. Commonly, small or
ultrasmall superparamagnetic iron oxide (SPIO, USPIO) nano-
particles are used for tracking of labeled cells. Accumulation of
these cells in tissues leads to focal signal loss on T2- and T2*-w
MRI. However, although relatively low numbers of iron-laden
cells can give a strong MRI signal void [1] confounding factors
such as blood pool effects and bleedings limit the strength of this
technique. Moreover, endogenous iron-laden macrophages can
give rise to signal loss even in the absence of contrast agents
especially at high field strength [2,3]. In 2005
19F MRI was
introduced as a novel imaging technique for in vivo cell tracking
after injection of ex vivo labeled cells [4]. In contrast to iron contrast
agents,
19F markers exhibit a unique MRI signal that can be
detected directly [5]. Due to the lack of
19F background signal in
the host’s tissue
19F MRI is extremely selective for the labeled cells.
However,
19F MRI requires high numbers of
19F spins to
accumulate in order to generate sufficient signal-to-noise ratio
(SNR). Previous studies have shown that systemic intravenous
injection of perfluorocarbons (PFC) leads to significant and
spontaneous PFC uptake by cells of the macrophage/monocyte
system [6,7]. By applying in vivo
19F MRI areas with macrophage
infiltration could be visualized in mice in myocardial and cerebral
infarctions [7] and in rodent models of acute allograft rejection
[8]. We could recently depict neuroinflammation in rats within
peripheral nerve lesions by
19F MRI [9].
In the present study we applied
19F MRI at different stages of
cerebral photothrombosis (PT) at high field strength of 7 Tesla (T).
In 1985, Watson et al. introduced brain PT as a simple model of
focal cerebral ischemia [10]. To achieve thrombosis a photosen-
sitive dye is injected systemically. Subsequent illumination through
the intact skull leads to local activation of the dye with free radical
formation and photoperoxidation of the endothelium. Endothelial
injury is then supposed to mediate clot formation in illuminated
vessels. Thus, the pathophysiology of PT lesion development
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e28143encompasses endothelial damage, breakdown of the blood brain
barrier (BBB) and rapid edema formation, but also occlusion of
vessels thereby partly mimicking cerebral ischemia [11]. More-
over, PT lesions elicit a strong, but delayed inflammatory reaction
[12]. While several factors such as the little ischemic penumbra
limit the strength of PT as a model for human stroke [13] it was
chosen in this study because lesions show a predictable pattern of
macrophage infiltration.
MRI studies at 1.5 T using SPIO in rats showed that in early
stages of PT lesion development ongoing vessel occlusion can be
visualized by iron-enhanced MRI [14], while delayed application
of SPIO depicted neuroinflammation [15]. To elucidate which
processes (acute damage versus late neuroinflammation) are
visualized in mice with PT we compared lesion development at
7 T after PFC/SPIO injection by
19F or T2-w MRI. Our results
suggest that
19F imaging and iron-enhanced MRI depict vessel
occlusion with high sensitivity in the early phase of photothrom-
botic infarction while at later stages the inflammatory response is
covered. The use of two different PFC markers, moreover, allowed
detection of stepwise microvascular occlusion in a single PT lesion.
In conclusion, the timing of contrast agent application was the
major determinant of the underlying processes depicted by these
two imaging techniques.
Materials and Methods
Photothrombotic infarction
Animal experiments were performed in accordance with
institutional guidelines and were approved by the institutional
ethics committee for animal welfare of the University of
Wu ¨rzburg, Germany (permit number 62.1-2531.01-23/04; 55.2-
2531.01-17/10). Focal cerebral ischemia was induced in 44 adult
C57/BL6-mice (25–30 g) by PT of cortical microvessels under
inhalation anesthesia with enflurane in a 2:1 nitrogen/oxygen
atmosphere, as described previously [15,16]. Briefly, a fiber optic
bundle of a cold light source was centered stereotactically 2 mm
posterior and 2.4 mm lateral from Bregma on the skull exposed
via a dorsal midline incision of the skin. 0.2 ml of a sterile-filtered
rose Bengal solution were given by intraperitoneal injection and
the brain was illuminated for 20 min. Subsequently the skin was
sutured and the mice were allowed to recover. This procedure
resulted in cone-shaped cortical infarctions. For MRI measure-
ments mice were anesthetized using 1.5% isoflurane in a 2 l/min
oxygen atmosphere.
Contrast agents/markers
PFC markers. A perfluoro-15-crown-5-ether emulsion (10%
wt/wt, Fluorochem Ltd. Glossop, UK) was used in experiments in
which only one PFC emulsion was applied. Production and
properties of are described in detail elsewhere [7].
For experiments applying two chemically shifted PFC com-
pounds multi-resonant perfluorooctlybromid (PFCA) was used.
The nanoemulsion contained 40% wt/wt PFCA (Chempur;
Karlsruhe, Germany) and 2.4% wt/wt purified soybean lecithin
S75 (Lipoid; Ludwigshafen, Germany) in an isotonic buffer (7 mM
Na2HPO4 -2H 2O, 3 mM NaH2PO4 -2H 2O, 2.5% glycerol,
pH 7.4) and was prepared as previously reported [7]. High
pressure homogenization (75 MPa, 10 cycles) with Emulsiflex C5
(Avestin; Mannheim, Germany) resulted in a particle size of
<240 nm as determined by dynamic light scattering (average of at
least ten runs measured at the stationary level) using Zetatrac
TM
(Particle Metrix; Meerbusch, Germany). The nanoemulsion was
sterilized by autoclavation and stored at 6uC until application.
Besides PFCA the single-resonant perfluoro-15-crown-5-ether
(PFCB) was used. The 30% v/v PFCB emulsion was obtained
from Celsense Inc. (Pittsburgh, PA, USA).
SPIO contrast agents. SPIO particles (Resovist
TM, Bayer
Schering Pharma AG, Berlin, Germany) were used in a dosage of
0.2 mmol Fe/kg body weight as described in previous studies at
1.5 T [15,17].
Hardware
All measurements were performed on a 7 T Bruker Biospec
System (Bruker BioSpin GmbH, Reinstetten, Germany) at room
temperature. For in vivo
1H and
19F imaging a home-built surface
coil adjustable to both frequencies was used. Ex vivo imaging of the
fixed mouse brains was performed with a home-built solenoid coil.
Additionally, a home-built, actively decoupled
19F birdcage coil in
combination with an actively decoupled
19F receive-only surface
coil was used for the experiments with two PFC compounds. Even
though the solenoid and the birdcage with integrated surface coil
were optimized for the
19F resonance frequency, their perfor-
mance was still sufficient to acquire
1H anatomical background
images.
In vivo
1H/
19F imaging
Experiments in the acute phase of lesion
development. In order to visualize and quantify different
stages of acute ‘‘ischemic’’ damage PFC emulsion was applied
via the tail vein in a dosage of 250 ml either directly after the end of
illumination (n=8) or two hours later (n=8). Two mice with
cortical infarctions that obtained 250 ml of 0.9% sodium chloride
intravenously instead of PFC served as negative controls.
MRI scans were performed 24 hours after PFC injection. In
n=8 animals (0 h/2 h=4/4) 2D single slice experiments were
performed. In all experiments the slice was located axially through
the middle of the infarction using information obtained from scout
scans. For
1H reference images, a turbo spin echo (TSE) sequence
was used (echo time (TE)/repetition time (TR): 40 ms/5000 ms;
inter-echo time: 10 ms; turbo factor: 8; field-of-view (FOV):
25625 mm; matrix: 2566256; slice thickness (SI): 2 mm; number
of averages (NA): 1). Regarding
19F imaging 2D steady-state free
precession CSI (SSFP-CSI) sequences [18] were performed with
the same geometry as the TSE scans (pulse shape: hermite; pulse
bandwidth: 5400 Hz; acquisition time(TAQ)/TR: 10.3 ms/
13.6 ms; FOV: 25625 mm; spectral points: 512; matrix: 41641;
SI: 2 mm; NA: 158). The overall protocol time was ,1.5 hours.
To be able to quantify the lesion volume 3D experiments were
performed in additional n=8 mice (0 h/2 h=4/4). Thus, 3D
acquisition weighted
19F SSFP-CSI data were acquired [19]. The
FOV was set to 25625620 mm, the matrix and the NA were
adjusted to allow the same nominal spatial resolution and total
imaging time as a 40640620 and 8 times averaged scan with full
coverage of the k-space. To eliminate banding artifacts an
additional 3D
19F SSFP-CSI scan with a 180u phase shift
alternation of the excitation pulse was performed. Additional
multislice (SI=1 mm)
1H TSE reference scans were performed
(otherwise same parameters as described above). For the
quantification study the overall protocol time was <2.5 hours.
Lesion maturation experiments. In order to follow the
19F
signal during lesion maturation qualitatively n=2 (2 h) mice
underwent additional 2D single slice MRI scans 3, 8 and 10 days
after PT as described above.
Different stages of acute ‘‘ischemic’’ damage visualized
in a single experiment. To visualize ongoing vessel occlusion
in the acute ‘‘ischemic’’ stage n=3 mice received 125 ml PFCA
emulsion intravenously directly after the end of illumination. Two
hours later 125 ml of PFCB was applied into the same animals.
In Vivo
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19F scans were performed at days three and eight after
PT. Multislice
1H TSE datasets of the mouse brain were acquired
for anatomical references (slices: 28; SI: 1 mm; FOV: 25625 mm;
matrix: 2566256). 3D
19F SSFP-CSI datasets without slice
selection were acquired using the same geometry as the
1H TSE
datasets (pulse shape: hard pulse; pulse bandwidth: 50000 Hz;
FOV: 25625628 mm; matrix: 41641614; NA: 6). The pulse
bandwidth was increased to 50000 Hz to excite the complete
spectrum of the PFCA compound. Otherwise the same parameters
were used as described above. The protocol time was ,1 hour.
Neuroinflammation experiments in the late stage of
PT. In n=8 mice the PFC emulsion was administered at day
6 when secondary invasion of hematogenous macrophages is
supposed to happen [12]. MRI measurement was carried 48 hours
later at day 8 to allow labeled macrophages more time to invade
into the photothrombotic lesion. The same scans were performed
as described for the volume quantification experiments. The
protocol time was ,2.5 hours.
Ex vivo
1H/
19F imaging
In vivo MRI of mice injected at day 6 did not exhibit fluorine
signal within the lesion. To clarify whether a lack of signal led to
insufficient sensitivity of in vivo imaging post mortem scans of the
isolated brain were performed. Mice were sacrificed after the in
vivo MRI measurement at day 8 by perfusion with 0.9% sodium
chloride followed by 4% paraformaldehyde in deep anesthesia.
The brains were removed in toto and fixed overnight in 4%
paraformaldehyde.
For
1H reference images, a multislice TSE sequence was used
(FOV: 15615 mm; matrix: 1286128; SI: 1 mm; 36 slices, otherwise
same parameters as in vivo
1H/
19F imaging). Regarding
19Fi m a g i n g
3D acquisition weighted SSFP-CSI scans were acquired with the
same geometry as the TSE scans. The matrix and the number of
averages were adjusted to allow the same nominal spatial resolution
and total imaging time as a 30630618 and 256 times averaged scan
with full coverage of the k-space. Otherwise same imaging
parameters as described in the in vivo
1H/
19F imaging section were
applied. The overall ex vivo protocol time was 16 hours.
In vivo SPIO-enhanced MRI
In accordance with the PFC injection protocol a parallel group of
mice (n=15) received SPIO intravenously immediately after the
end of illumination (n=4), two hours later (n=4) or at day 6 (n=7).
MRI measurements were performed 24 hours after systemic
administration of the contrast agent. For MRI T2-w imaging the
same single slice TSE sequences as for the anatomical reference in
the
19F in vivo experiments were used. Furthermore, multislice
(SI=1 mm) TSE measurements were performed. The total
protocol time for the in vivo SPIO measurements was ,30 minutes.
Ex vivo SPIO-enhanced MRI
Mice with delayed application of SPIO at day 6 were sacrificed
after the in vivo MRI scan by perfusion with 0.9% sodium chloride
followed by 4% paraformaldehyde in deep anesthesia. The brains
were removed in toto and fixed overnight in 4% paraformalde-
hyde. Two post mortem T2*-w 3D fast low angle shot (FLASH)
scans of the brain were obtained (TE/TR: (4 ms/20 ms)/50 ms;
FOV: 15615636 mm; matrix: 15061506360; NA: 4). Each ex
vivo FLASH scan lasted three hours.
Post Processing
All post processing was done in MATLAB (The MathWorks
Inc., Natick, USA). Thereby semi-automated, home-written
algorithms were used for quantification experiments as described
below. Quantification was performed independently by three
different persons.
19F imaging. To generate
19F images only the signal of the
19F peak was integrated. Furthermore, a threshold was applied to
the
19F data and afterwards overlaid with the
1H TSE data. For
each overlay image the threshold was adjusted individually.
Regarding quantification, sum-of-squares (SOS) reconstructions
were generated of the data with and without alternating phase to
minimize banding artifacts in a first step. In a second step the signal
of the
19F peak was integrated to generate
19F images. Afterwards
the 3D
19F dataset was zerofilled to the size of the
1H reference
dataset(2566256620).Forall
19Fdatasets,thevolumeoftheinfarct
containing
19F signal was evaluated by only counting pixels with
19F
signal greater than a threshold value set by the investigator.
Thereby, only the pixels of the
19F dataset in the infarct area were
regarded. The infarct area was manually segmented by the
investigator using the contrast of the
1H reference dataset (positive
T2 contrast) prior to the
19F quantification.
SPIO-enhanced MRI. For quantification, the infarct area
was manually segmented by the investigator using the contrast of
the
1H reference dataset (positive/negative T2 contrast). In a
second step the volume of the infarct showing signal voids was
calculated by only counting pixels with SNR lower than a
threshold value defined by the investigator.
Histology
After the ex vivo MRI PFA-fixed brains were washed in
phosphate-buffered saline (PBS) and embedded in paraffin.
Subsequently 5 mm thick coronal sections were cut at multiple
levels through the infarction, deparaffinized with xylene, rehy-
drated and washed in water and PBS. For iron detection tissue
sections were rinsed in deionized water and immersed in Perl’s
solution containing 2% potassium ferrocyanide and 2% HCl at a
1:1 concentration for 30 minutes. Sections were then rinsed in
deionized water and either dehydrated, counter stained with
hematoxylin-eosin and coverslipped or further processed for
immunohistochemistry. Immunohistochemistry was performed
using von Willebrand Factor (vWF) (polyclonal rabbit anti-mouse
IgG, ab6994, 1:800; Abcam, USA), an endothelial cell marker, as
primary antibody upon the same sections. Enzymatic antigen
retrieval was performed with 0.1% pronase for 10 min at 35uC.
Binding of the antibodies to cells was visualized by a biotinylated
goat anti-rabbit IgG secondary antibody (1:100, Vector laborato-
ries, USA). For negative controls, the primary antibody was
omitted from the diluent.
Results
19F and iron-enhanced MRI in early stages of infarct
development
In a first set of experiments mice received either PFC emulsion
or SPIO directly after the end of illumination of the brain or with
two hours delay. Control animals with cortical infarctions but no
PFC injections did not exhibit fluorine signal under inhalation
anesthesia with isoflurane (data not shown).
Administration of PFC directly after illumination led to a bright
19F signal throughout the entire cortical infarction as shown on the
in vivo MRI scan 24 hours later (Fig. 1A). When PFC were injected
with two hours delay lesions displayed a ring-like fluorine signal at
the lesion margins (Fig. 1A). The rim-like fluorine signal seen at
day 1 persisted when individual 2 h-animals were scanned again
during further lesion maturation at days 3, 8 and 10 (Fig. 2). On
1H-TSE images the lesions initially appeared hyperintense. Within
In Vivo
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to an almost isointense tissue signal at day 8 (Fig. 2B). The
semilunar
19F signal appeared more intense with shrinkage of the
lesion over time (Fig. 2B).
The distribution of the signal loss on T2-w MRI after SPIO
injection closely resembled the
19F signal following PFC
administration directly after illumination or with a delay of
2 hours. Whereas in animals which obtained SPIO immediately
Figure 1. In vivo imaging patterns of
19F and SPIO-enhanced MRI in the acute stage of cerebral photothrombosis. (A) All images were
acquired 24 hours after PT induction. The
1H/
19F overlay shows fluorine signal within the entire cortical infarction when PFC were applied directly
after the end of illumination (left, upper image). Delayed injection two hours later led to a rim-like signal in the boundary zone (left, lower image).
Note the similar distribution pattern of signal loss on T2-w MRI when SPIO were administered immediately after illumination (right, upper image) and
with two hours delay (right, lower image). The relative volume of iron-induced signal loss and
19F signal in proportion to the total infarct volume
decreased from 0.8560.13/0.6160.13 to 0.5960.03/0.2960.08 (PFC/SPIO) within the first two hours after illumination (B) (both cases p,0.05). When
corresponding time points of SPIO/
19F marker injection were compared a significant difference was found between the volume fraction showing
19F
signal and the signal voids in SPIO-enhanced MRI (p,0.05).
doi:10.1371/journal.pone.0028143.g001
Figure 2. Development of the
19F signal during lesion maturation. Individual animals that received PFC two hours after photothrombotic
infarction were scanned sequentially on days 1, 3, 8 and 10 (A). On
1H-TSE lesions initially appeared hyperintense due to increased T2 values caused
by tissue damage and edema formation. Over time proton signal changes decrease leading to an almost isointense tissue signal at day 8 (B). The rim-
like fluorine signal seen one day after PT induction persisted until day 10 and appeared even more intense with shrinkage of the lesion over time. An
additional fluorine signal could be observed at the site of skin incision (arrows).
doi:10.1371/journal.pone.0028143.g002
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depicted on T2-w MRI, injection with 2 hours delay led to a
hyperintense infarct core with a hypointense ring at the lesion
margins (Fig. 1A). Furthermore, using statistical t-tests the
quantification of each of the three independent researchers
revealed a significant difference between the
19F volume fractions
of the lesions when the PFC emulsion was injected 0 h or 2 h after
the illumination (p,0.05). Similarly, the volume fractions showing
signal voids in SPIO-enhanced MRI 0 h and 2 h after the
illumination significantly differed (p,0.05). However, when
corresponding time points of SPIO/PFC injection were compared
a significant difference was found between the volume fraction
showing
19F signal and the signal voids in SPIO-enhanced MRI
(both cases: p,0.05). Thus, the mean volume fraction and mean
error of the lesion exhibiting
19F signal was 0.8560.13/0.5960.03
(0 h/2 h) and 0.6160.13/0.2960.08 (0 h/2 h) for the iron-
enhanced experiments (Fig. 1B). A relative measurement of the
volume fraction was chosen due to a certain interindividual
variance of the stroke volumes. Therefore, total quantification
could have generated misleading results with high standard
deviations.
In vivo visualization of different stages of acute
‘‘ischemic’’ damage. Additional 3D CSI experiments with
two chemically shifted PFC compounds were performed which
allowed differentiation of both markers and thus visualization of
ongoing vessel occlusion in a single MRI measurement (Fig. 3).
Administration of the first emulsion (PFCA) directly after induction
of PT led to a fluorine signal throughout the cortical infarction
(Fig. 3C). The second
19F marker (PFCB) that was applied two
hours later, however, accumulated at the outer margins sparing
the center of the infarcted zone (Fig. 3C). By merging the signals
on a
1H background image the different spatial distribution of the
compounds could be identified in a single measurement (Fig. 3C).
19F and iron-enhanced MRI in late stages of infarct
development: Visualization of neuroinflammation
When the PFC emulsion was administered with a delay of 6
days after PT and animals were scanned at day 8 no fluorine signal
was detectable within the lesions on in vivo
19F MRI scans (Fig. 4A).
The
19F marker was only visible at the site of the skin incision on
the skull (Fig. 4A, arrow). However, when mice were sacrificed
after the in vivo measurement and post mortem scans of the isolated
brain with long acquisition times and the use of a more sensitive
solenoid coil were performed a fluorine signal in the ischemic
lesion was regularly detectable (Fig. 4B). After SPIO application at
day 6 a small rim of signal loss was regularly visible on in vivo T2-w
MRI (Fig. 4C) as shown previously for rats at 1.5 T [15]. The ring-
like hypointensity was even more prominent on ex vivo T2*-w MRI
scans of the removed brain (Fig. 4D). Proton signal changes in PT
decrease during the first week leading to an almost isointense
infarct signal at day 8 so that quantification of the
19F signal in
relation to the total infarct volume was impossible at this late stage
of lesion development.
Histological analysis
Macroscopically the circular PT lesions could be identified at
the frontoparietal cortex as shown previously [20]. Prussian blue
staining on coronal sections cut through the infarction of mice
sacrificed one day after PT induction revealed entrapment of iron
particles throughout the infarct core when SPIO were applied
directly after the end of the illumination (Fig. 5A). The
intravascular location of the iron deposits was confirmed by co-
staining of identical sections with antibodies against vWF, an
endothelial cell marker (Fig. 5A–C). Iron particles could only be
detected within the vessel lumina in the infarct region, but not in
the brain parenchyma or remote cortex. After two hours delay the
iron nanoparticles were trapped in the cortical vessels at the outer
margin of the infarction while vessel thrombi in the center of the
lesion were devoid of iron particles (Fig. 5B). This finding supports
our MRI results depicting ongoing vessel occlusion despite
cessation of the illumination exclusively in the periphery of the
photothrombotic lesion. At late lesion stages eight days after PT
induction accumulation of blue iron particles was no longer found
in the vessel lumina but intracellular within the infarcted zone
(Fig. 5D). These findings correspond to previous results obtained
in rats [14].
Discussion
As principal finding we show that
19F MRI can visualize
ongoing vessel occlusion and cellular infiltration in cortical PT, a
model of focal cerebral ischemia. The timing of contrast agent
application was the major determinant of the underlying processes
depicted by
19F MRI.
19F and iron-enhanced MRI in early stages of infarct
development
When the PFC emulsion was injected directly after PT
induction the fluorine signal was displayed throughout the entire
lesion. Two hours delay led to a fluorine rim at the periphery of
the infarction. Both changes were present during the acute phase
of lesion formation in which hematogenous macrophages are not
yet significantly involved [12,15]. Signal alterations visualized by
19F imaging during acute PT closely resembled the pattern of
signal loss on T2-w MRI after application of SPIO. However, the
relative volume fractions showing a
19F signal or signal voids in
SPIO-enhanced MRI at corresponding injection time points
differed significantly. This might on one hand be due to partial
volume effects leading to an overestimation of the
19F signal as
only a relatively low spatial in-plane resolution could be obtained.
On the other hand, PFC emulsions and SPIO have different blood
clearance times. The PFC emulsion which was used in the present
study for quantification experiments was shown to circulate in the
blood up to two days [7]. In contrast, SPIO concentrations
significantly decline in the circulation within the first hour after
application due to uptake of the iron particles in the reticuloen-
dothelial system of the liver [21]. On tissue sections iron deposits
could be exclusively found in vessels of the infarct core when SPIO
were applied directly after the end of the illumination while SPIO
injection two hours later lead to intravascular entrapment of the
iron particles mainly at the outer margins of the lesion indicating
ongoing vessel occlusion despite cessation of the illumination. The
same mechanism very likely underlies the fluorine signal observed
in the early phase of photothrombotic stroke in our study.
19F and iron-enhanced MRI in late stages of infarct
development
Unlike the in vivo
19F MRI in the early stage of infarct
development no intracranial fluorine signal could be detected in
vivo when the PFC emulsion was applied with a delay of six days
after PT. However, ex vivo
19F MRI with long acquisition times and
use of a more sensitive coil disclosed a fluorine signal within the PT
lesions at this late lesion stage most likely reflecting the infiltration
of fluorine-labeled macrophages from the blood.
Several groups have already shown the uptake of PFC in
activated macrophages [6,7,8]. In their work, Flo ¨gel and
colleagues [7] focused on cellular infiltration after myocardial
infarction, but also studied
19F MRI in the PT model. In contrast
In Vivo
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emulsion, two hours after PT induction and six days later, was
used. Interestingly, the two hours delayed PFC administration in
our study led to a ring-like appearance similar to the
19F TSE MRI
scans shown after day 7 by Flo ¨gel et al. [7]. Their histological
analysis performed seven days after PT induction confirmed co-
localization of rhodamine-labeled PFC with CD11b-positive
macrophages/microglia in the PT lesions. Importantly, the
rhodamine-labeled PFC emulsion was only used for the second
injection at day 6 indicating that the observed macrophage/
microglia labeling could only be due to this injection. Although in
our study no intracranial
19F signal was detectable in vivo when
PFC were applied at day 6 and the first injection two hours after
illumination was omitted, ex vivo scans of the removed brain after
long acquisition times regularly revealed the fluorine marker
within the infarcted zone. Thus, in our hands the fluorine signal
generated by intravascular trapping of the PFC emulsion early
during PT was much stronger than the signal intensity obtained by
macrophage invasion into the mature PT lesion at later points of
time.
Previously it was shown in rats that late SPIO application at
days 5 or 6 after PT leads to a hypointense rim around the lesion
on in vivo 1.5 T MRI due to accumulation of SPIO-laden
hematogenous macrophages [15,22]. In our 7 T study in mice this
Figure 3. In vivo visualization of ongoing vessel occlusion. A subgroup of animals received two chemically shifted PFC compounds
sequentially. PFCA with a multi-resonant perfluorooctlybromid was administered immediately after the end of illumination while single-resonant PFCB
with a peak at 90 ppm was injected with two hours delay (A,B). Representative coronal slides of the mouse brain 3 and 8 days after induction of the
photothrombotic infarction are shown (C). Administration of the first emulsion (PFCA, blue) directly after induction of PT led to a fluorine signal
throughout the cortical infarction (C2) while the second
19F marker (PFCB, red) that was applied two hours later accumulated at the outer margins
sparing the center of the infarcted zone (C3). Combined overlay of the
1H TSE data with data from both PFC compounds allowed visualization of the
distinct marker distribution in a single 3D in vivo measurement (C4). Similar to the previous experiments an additional
19F signal of both compounds
can be observed at the site of the skin incision.
doi:10.1371/journal.pone.0028143.g003
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PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e28143finding could be confirmed by in vivo T2-w MRI at day 8 showing
a small rim of signal loss at the boundaries of the lesions. T2-w
instead of T2*-w MRI was chosen since T2*-w in vivo studies at
this high field strength can be hampered by significant
susceptibility artifacts. Importantly, histological evaluation at this
late stage of lesion development showed iron deposits merely
intracellular, but not in the vessel lumina.
It is well established that PT lesions induce early and persistent
breakdown of the BBB within the lesion and transiently for 24 h
within the entire, morphologically intact ipsilateral cortex [23,24].
Although PFC and SPIO are likely to pass through a broken BBB,
the timely and locally restricted patterns of
19F (this study) and
SPIO enhancement [14,15] are not compatible with passive
accumulation of these contrast agents within the lesion as seen
with the conventional MR contrast agent Gadolinium (Gd)-DTPA
[15]. PT lesions become Gd-DTPA enhanced on T1-w MRI
within hours after induction and Gd-DTPA-uptake lasts up to
weeks [25]. In contrast
19F- and SPIO-enhancement follows
distinct patterns reflecting either acute vessel occlusion or
inflammation, but not merely leakage of the BBB. The lack of
perivascular or parenchymal iron accumulation in the acute PT
lesions also argues against passive diffusion of the contrast agents
into the brain parenchyma.
19F MRI is a relatively new experimental imaging technique
which still depends on customized coil manufacture and individual
sequence adaption. This could explain some of the discrepancies
described above. Since the fluorine signal in the PT model is
located near the surface, we used self-made surface coils for the in
vivo experiments. This setup yields improved SNR compared to a
volume resonator [26]. Moreover, a
19F SSFP-CSI sequence
instead of a
19F TSE MRI sequence, a reduced in-plane resolution
and a longer acquisition time were chosen which could explain the
higher sensitivity of our approach during early PT. However,
sensitivity of our set-up appears not to be strong enough for in vivo
detection of intracerebral cell-bound fluorine while it worked well
in sciatic nerves [9]. Improved hardware and adapted
19F
sequences might help to overcome this restriction for imaging of
brain neuroinflammation in the future.
The key advantage of
19F MRI is its high selectivity due to the
negligible
19F background signal in mammals. With use of iron-
enhanced MRI it often remains difficult to unequivocally assign
alterations in local contrast to accumulation of iron nanoparticles
and not to other field inhomogeneities. Moreover, the prominent
iron-related signal loss eight days after PT in our study could
partly be caused by intrinsic iron loading of macrophages during
vascular degeneration [3] or following hemorrhage as shown by
Jolkkonen et al. [2]. Thus,
19F MRI might help to overcome the
limitations of iron-enhanced MRI in the future (reviewed in [27]).
Another virtue of
19F MRI is that it allows in vivo discrimination of
different PFC compounds with large chemical shifts in acceptable
measurement times [28]. Thus, using a photothrombotic lesion
Figure 4. In vivo and ex vivo
19F and SPIO-enhanced MRI in late
stages of infarct development. (A) shows an in vivo
1H/
19F overlay
of the infarcted zone when PFC were administered six days after PT
induction. Note the lack of fluorine signal within the lesion. The
19F
marker is only visible at the site of skin incision (dashed arrow). Post
mortem scans of the removed brain with long acquisition times
revealed a fluorine signal in the ischemic lesion (arrow in panel B).
Application of SPIO led to a ring-like signal loss indicative of
macrophage infiltration (arrows in panel C/D) which was weakly visible
on in vivo T2-w MRI at 7T (C), but very prominent on ex vivo T2*-w MRI
scans (D).
doi:10.1371/journal.pone.0028143.g004
Figure 5. Histological analysis of the infarctions at different
time points after photothrombotic stroke. Localization of SPIO
particles in focal cerebral infarctions 24 hours after PT induction. In (A)
SPIO particles were injected directly after the end of illumination, in (B)
with a delay of two hours. Coronal paraffin sections cut through the
infarction were additionally immunolabeled with vWF antibody to
unequivocally identify cerebral endothelial cells. SPIO particles by Perl’s
stain appear in blue. Note iron deposits throughout the core of the
infarcted area in cerebral vessels stained by vWF in (A). (B) shows the
outer border of the ischemic zone on the left lower part and the core
region on the right upper part. The iron entrapment after two hours
delayed injection is now restricted to vessels in the left border zone
(blue arrows) while vWF positive vessels in the center of the lesion are
devoid of iron particles (red arrows). A higher magnification illustrates
the localization of the iron particles inside the vessels identified by
staining against vWF. (D) In contrast, blue appearing iron particles are
no longer found in the vessel lumina but are located within the
cytoplasm of cells (black arrows) representing macrophages [14,22]
when SPIO are applied at late stages of lesion development (day 6).
Magnifications (A) 406, (B) 406, (C) 1006, (D) 1006.
doi:10.1371/journal.pone.0028143.g005
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PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e28143model we were the first to monitor stepwise thrombus formation
from the core of the infarction to its outer margin in a single MRI
measurement. Further studies are required to clarify whether
19F
MRI can be applied to stroke models with different lesion
dynamics.
Taken together we have shown that the application scheme of
PFC has a major impact on the interpretation of MR findings in
different organs. In brain ischemia vascular trapping during
thrombus formation is an important component which may
prevail over macrophage infiltration. Overall, it seems that
visualization of cellular infiltration by
19F imaging in the central
nervous system is much more difficult than in other organs such as
the heart, lung and peripheral nerve [6,7,9] due to lower signal
intensities and requires further technical development.
Acknowledgments
We thank Profs. Flo ¨gel and Schrader (Du ¨sseldorf) for providing the PFC
emulsions, Melanie Glaser, Gabi Ko ¨llner and Sabine Voll for expert
technical assistance and Sebastian Fiedler for building the MR coils.
Author Contributions
Conceived and designed the experiments: GW TBL GS. Performed the
experiments: GW TBL CK. Analyzed the data: GW TBL TK.
Contributed reagents/materials/analysis tools: GW TBL PMJ GS. Wrote
the paper: GW TBL GS.
References
1. Shapiro EM, Sharer K, Skrtic S, Koretsky AP (2006) In vivo detection of single
cells by MRI. Magn Reson Med 55: 242–249.
2. Jolkkonen J, Jokivarsi K, Laitinen T, Grohn O (2007) Subacute hemorrhage and
resolution of edema in Rose Bengal stroke model in rats coincides with improved
sensorimotor functions. Neurosci Lett 428: 99–102.
3. Weber R, Wegener S, Ramos-Cabrer P, Wiedermann D, Hoehn M (2005) MRI
detection of macrophage activity after experimental stroke in rats: new indicators
for late appearance of vascular degradation? Magn Reson Med 54: 59–66.
4. Ahrens ET, Flores R, Xu H, Morel PA (2005) In vivo imaging platform for
tracking immunotherapeutic cells. Nat Biotechnol 23: 983–987.
5. Stoll G, Bendszus M (2010) New approaches to neuroimaging of central nervous
system inflammation. Curr Opin Neurol 23: 282–286.
6. Ebner B, Behm P, Jacoby C, Burghoff S, French BA, et al. (2010) Early
assessment of pulmonary inflammation by 19F MRI in vivo. Circ Cardiovasc
Imaging 3: 202–210.
7. Flo ¨gel U, Ding Z, Hardung H, Jander S, Reichmann G, et al. (2008) In vivo
monitoring of inflammation after cardiac and cerebral ischemia by fluorine
magnetic resonance imaging. Circulation 118: 140–148.
8. Hitchens TK, Ye Q, Eytan DF, Janjic JM, Ahrens ET, et al. (2011) 19F MRI
detection of acute allograft rejection with in vivo perfluorocarbon labeling of
immune cells. Magn Reson Med 65: 1144–1153.
9. Weise G, Basse-Luesebrink TC, Wessig C, Jakob PM, Stoll G (2011) In vivo
imaging of inflammation in the peripheral nervous system by (19)F MRI. Exp
Neurol 229: 494–501.
10. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD (1985)
Induction of reproducible brain infarction by photochemically initiated
thrombosis. Ann Neurol 17: 497–504.
11. Dietrich WD, Watson BD, Busto R, Ginsberg MD, Bethea JR (1987)
Photochemically induced cerebral infarction. I. Early microvascular alterations.
Acta Neuropathol 72: 315–325.
12. Schroeter M, Jander S, Huitinga I, Witte OW, Stoll G (1997) Phagocytic
response in photochemically induced infarction of rat cerebral cortex. The role
of resident microglia. Stroke 28: 382–386.
13. Carmichael ST (2005) Rodent models of focal stroke: size, mechanism, and
purpose. NeuroRx 2: 396–409.
14. Kleinschnitz C, Schutz A, Nolte I, Horn T, Frank M, et al. (2005) In vivo
detection of developing vessel occlusion in photothrombotic ischemic brain
lesions in the rat by iron particle enhanced MRI. J Cereb Blood Flow Metab 25:
1548–1555.
15. Kleinschnitz C, Bendszus M, Frank M, Solymosi L, Toyka KV, et al. (2003) In
vivo monitoring of macrophage infiltration in experimental ischemic brain
lesions by magnetic resonance imaging. J Cereb Blood Flow Metab 23:
1356–1361.
16. Schroeter M, Jander S, Stoll G (2002) Non-invasive induction of focal cerebral
ischemia in mice by photothrombosis of cortical microvessels: characterization of
inflammatory responses. J Neurosci Methods 117: 43–49.
17. Bendszus M, Stoll G (2003) Caught in the act: in vivo mapping of macrophage
infiltration in nerve injury by magnetic resonance imaging. J Neurosci 23:
10892–10896.
18. Speck O, Scheffler K, Hennig J (2002) Fast 31P chemical shift imaging using
SSFP methods. Magn Reson Med 48: 633–639.
19. Pohmann R, von Kienlin M (2001) Accurate phosphorus metabolite images of
the human heart by 3D acquisition-weighted CSI. Magn Reson Med 45:
817–826.
20. Lee JK, Park MS, Kim YS, Moon KS, Joo SP, et al. (2007) Photochemically
induced cerebral ischemia in a mouse model. Surg Neurol 67: 620–625;
discussion 625.
21. Bulte JW, Kraitchman DL (2004) Iron oxide MR contrast agents for molecular
and cellular imaging. NMR Biomed 17: 484–499.
22. Schroeter M, Saleh A, Wiedermann D, Hoehn M, Jander S (2004)
Histochemical detection of ultrasmall superparamagnetic iron oxide (USPIO)
contrast medium uptake in experimental brain ischemia. Magn Reson Med 52:
403–406.
23. Stoll G, Kleinschnitz C, Meuth SG, Braeuninger S, Ip CW, et al. (2009)
Transient widespread blood-brain barrier alterations after cerebral photo-
thrombosis as revealed by gadofluorine M-enhanced magnetic resonance
imaging. J Cereb Blood Flow Metab 29: 331–341.
24. van Bruggen N, Cullen BM, King MD, Doran M, Williams SR, et al. (1992) T2-
and diffusion-weighted magnetic resonance imaging of a focal ischemic lesion in
rat brain. Stroke 23: 576–582.
25. Schroeter M, Franke C, Stoll G, Hoehn M (2001) Dynamic changes of magnetic
resonance imaging abnormalities in relation to inflammation and glial responses
after photothrombotic cerebral infarction in the rat brain. Acta Neuropathol
101: 114–122.
26. Edelman RR, McFarland E, Stark DD, Ferrucci JT, Jr., Simeone JF, et al.
(1985) Surface coil MR imaging of abdominal viscera. Part I. Theory, technique,
and initial results. Radiology 157: 425–430.
27. Stoll G, Bendszus M (2009) Imaging of inflammation in the peripheral and
central nervous system by magnetic resonance imaging. Neuroscience 158:
1151–1160.
28. Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, et al. (2007) 19F
magnetic resonance imaging for stem/progenitor cell tracking with multiple
unique perfluorocarbon nanobeacons. FASEB J 21: 1647–1654.
In Vivo
19F-Imaging of Stepwise Vessel Occlusion
PLoS ONE | www.plosone.org 8 December 2011 | Volume 6 | Issue 12 | e28143